Qurin®, a research and development company focused on urine-based liquid biopsy diagnostics in oncology, announces the launch of the ...
QIAGEN is also introducing the QIAGEN Discovery Platform, which enables the integration of AI with QIAGEN’s biomedical knowledge base and molecular data to support drug discovery. The platform is ...
XtalPi Holdings Limited (HKEX: 2228), an AI and robotics-driven drug and materials discovery company, today debuted Kodexiaâ„¢, the industry's first closed-loop small interfering RNA (siRNA) discovery ...